amiodarone has been researched along with Weight Reduction in 6 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To delineate the incidence, clinical features, diagnosis, and treatment options for amiodarone induced hyperthyroidism (AIH), we reviewed the medical records of ten patients with AIH." | 8.79 | Amiodarone induced hyperthyroidism: a case series and brief review of literature. ( Harjai, KJ; Licata, AA, 1996) |
| "Obesity is associated with an increased risk of development of chronic heart failure, but recent epidemiological studies indicate that a higher body mass index (BMI) is associated with a better survival rate." | 5.34 | [Combined therapy with weight loss and amiodarone improved cardiac function in a patient with idiopathic dilated cardiomyopathy complicated with severe obesity: a case report]. ( Kawano, S; Kozai, T; Tanaka, H; Urabe, Y, 2007) |
| "To delineate the incidence, clinical features, diagnosis, and treatment options for amiodarone induced hyperthyroidism (AIH), we reviewed the medical records of ten patients with AIH." | 4.79 | Amiodarone induced hyperthyroidism: a case series and brief review of literature. ( Harjai, KJ; Licata, AA, 1996) |
| "Amiodarone treated PPARα(-/-) mice exhibited significantly greater weight loss and higher serum aspartate aminotransferase (AST) compared to PPARα(+/+) mice." | 1.36 | Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice. ( Ernst, MC; Pollak, PT; Sinal, CJ, 2010) |
| "Obesity is associated with an increased risk of development of chronic heart failure, but recent epidemiological studies indicate that a higher body mass index (BMI) is associated with a better survival rate." | 1.34 | [Combined therapy with weight loss and amiodarone improved cardiac function in a patient with idiopathic dilated cardiomyopathy complicated with severe obesity: a case report]. ( Kawano, S; Kozai, T; Tanaka, H; Urabe, Y, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ernst, MC | 1 |
| Sinal, CJ | 1 |
| Pollak, PT | 1 |
| Duello, KM | 1 |
| Louh, IK | 1 |
| Burger, CD | 1 |
| Pantos, C | 1 |
| Mourouzis, I | 1 |
| Paizis, I | 1 |
| Malliopoulou, V | 1 |
| Xinaris, Ch | 1 |
| Moraitis, P | 1 |
| Cokkinos, AD | 1 |
| Cokkinos, DV | 1 |
| Tanaka, H | 1 |
| Kawano, S | 1 |
| Kozai, T | 1 |
| Urabe, Y | 1 |
| Bourron, O | 1 |
| Ciangura, C | 1 |
| Bouillot, JL | 1 |
| Massias, L | 1 |
| Poitou, C | 1 |
| Oppert, JM | 1 |
| Harjai, KJ | 1 |
| Licata, AA | 1 |
1 review available for amiodarone and Weight Reduction
| Article | Year |
|---|---|
Amiodarone induced hyperthyroidism: a case series and brief review of literature.
Topics: Amiodarone; Female; Goiter; Humans; Hyperthyroidism; Male; Middle Aged; Thyroid Hormones; Time Facto | 1996 |
5 other studies available for amiodarone and Weight Reduction
| Article | Year |
|---|---|
Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Aspartate Aminotransferases; Dose-Response Relationship | 2010 |
48-Year-old woman with dyspnea, cough, and weight loss.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cough; Diagnosis, Differential; Drug-Relate | 2012 |
Pharmacological inhibition of TRalpha1 receptor potentiates the thyroxine effect on body weight reduction in rats: potential therapeutic implications in controlling body weight.
Topics: Amiodarone; Animals; Dronedarone; Drug Synergism; Eating; Rats; Rats, Wistar; Thyroid Hormone Recept | 2007 |
[Combined therapy with weight loss and amiodarone improved cardiac function in a patient with idiopathic dilated cardiomyopathy complicated with severe obesity: a case report].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Body Mass Index; Cardiomyopathy, Dilated; Diet, Reducing; | 2007 |
Amiodarone-induced hyperthyroidism during massive weight loss following gastric bypass.
Topics: Amiodarone; Anti-Arrhythmia Agents; Gastric Bypass; Humans; Hyperthyroidism; Male; Middle Aged; Obes | 2007 |